|
| |
| | | 65676 | | 21.04.2016 | | Otsuka Pharmaceutical (Switzerland) GmbH | | | | | | | | | | | | | 05.02. | | | | 05.02. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Jinarc 15 mg | Tabletten | Tablets (Tolvaptanum 15 mg) | C03XA01 | CI | | 02 | Jinarc 30 mg | Tabletten | Tablets (Tolvaptanum 30 mg) | C03XA01 | CI | | 03 | Jinarc 45 mg + 15 mg | Tabletten | Tablets (Tolvaptanum 45 mg) + Tablets (Tolvaptanum 15 mg) | C03XA01 | CI | | 04 | Jinarc 60 mg + 30 mg | Tabletten | Tablets (Tolvaptanum 60 mg) + Tablets (Tolvaptanum 30 mg) | C03XA01 | CI | | 05 | Jinarc 90 mg + 30 mg | Tabletten | Tablets (Tolvaptanum 90 mg) + Tablets (Tolvaptanum 30 mg) | C03XA01 | CI |
|
|
|
